WA Parliamentary Question on Notice regarding the number of children and adolescents receiving treatment at the Perth Children's Hospital Gender Diversity Service between 2016 and 2020, including details on puberty blockers and cross-sex hormones.

AnsweredQoN 3Legislative Council
Asked
4 May 2021
Portfolio
Health

QuestionView source ↗

(1) How
many children and adolescents received treatment at the Perth Children's Hospital
Gender Diversity Service in the 2016, 2017, 2018, 2019 and 2020 calendar years? (2) What
constitutes ‘treatment’ for the numbers provided in (1)? (3) How
many children and adolescents commenced stage one puberty blocker treatment at
the Perth Children's Hospital Gender Diversity Service in the 2016, 2017, 2018,
2019, 2020 calendar years? (4) How
many children are currently receiving stage one puberty blocker treatment at
the Perth Children's Hospital Gender Diversity Service? (5) How
many children commenced stage two cross sex hormone treatment at the Perth
Children's Hospital Gender Diversity Service in the 2016, 2017, 2018, 2019,
2020 calendar years? (6) How
many children and adolescents are currently receiving stage two cross sex
hormone treatment at the Perth Children's Hospital Gender Diversity Service? (7) What
was the age of the youngest child to receive treatment at the Perth Children’s
Hospital in each of the years 2016, 2017, 2018, 2019 and 2020? (8) What
is the age of the youngest child who is currently receiving treatment at the
Perth Children's Hospital Gender Diversity Service?

AnswerView source ↗

Answered
1 June 2021
Responded by
Minister for Mental Health representing the Minister for Health
Response time
9 days
I am advised:
(1)
Year
Stage One
Stage Two
2016
14
7
2017
28
17
2018
47
21
2019
47
38
2020
49
47
(2) ‘Treatment’ is defined as those patients who are pubertal and who are treated with puberty suppression (“Stage One”) or estrogen or testosterone (“Stage Two”).
(3)
Year
Commenced Stage One
2016
14
2017
22
2018
35
2019
28
2020
25
(4)  44 currently receiving Stage One puberty blocker treatment.
(5)
Year
Commenced Stage Two
2016
6
2017
10
2018
15
2019
31
2020
29
(6) 43 currently receiving Stage Two cross sex hormone treatment.
(7)
Year
Stage One
Stage Two
2016
9 years 2 mths
15 years 2 mths
2017
12 years 8 mths
16 years 2 mths
2018
10 years 8 mths
15 years 9 mths
2019
10 years 10 mths
15 years 10 mths
2020
10 years 11 mths
15 years 1 mth
(8) Youngest patient currently receiving puberty suppression (Stage One): 11 years 4 months.
Youngest patient currently receiving hormone therapy (Stage Two): 15 years 5 months.

Explore WA Government Data

Search the full archive in the free dashboard, or query programmatically via API.

Explore more